Search Results:

Treat-to-Target in Giant Cell Arteritis & Polymyalgia Rheumatica- A New Approach for Improved Outcomes

16 February, 2025

The treat-to-target approach offers a promising framework for improving the management of GCA and PMR. By setting clear treatment goals, regularly monitoring disease activity, and adjusting therapies based on individual patient needs, clinicians can better control these chronic conditions and minimize treatment-related complications.

Predicting patient responses to COVID-19 immunotherapies

06 December 2022

According to data from a phase 2 trial, researchers have discovered inflammatory markers that may help identify COVID-19 patients who are more likely to react to treatments like the anti-cancer medicine pacritinib…

Keep up while the storm is raging

Norberto, a 23-year old white male in his third relapse of a B cell acute lymphoblastic leukemia (B-ALL) has been treated with an infusion of autologous CD19 Chimeric Antigen Receptor (CAR) T cells (CAR-T cells). Ten days later, he felt severe discomfort in the middle of the night…

IUIS Webinar: What cancer immunologists are doing about COVID-19 ?

14th May

Did you watch the IUIS Webinar : “What cancer immunologists are doing about COVID-19?” by Rachel Humphrey, a medical oncologist, who is currently serving as Head of Research and Development for TIO Bioventures. Highlights from her talk include: Intersection in advances in cancer and infectious diseases immunology…

COVID-19 – Cytokine storm syndromes and immunosuppression

25th March

Mehat, P. et al recently stated that there is accumulating evidence suggests that a subgroup of patients with severe COVID-19 might have cytokine storm syndrome. Immunosuppression treatment could help severe COVID-19 patients.

A case of lymphadenopathy and night sweats

A 33 year old male presents with a one month history of a non-productive cough, fever, night sweats, malaise, abdominal pain and weight loss. History: Known HIV positive, Diagnosed 8 months previously but not on ARV’s. Past medical history: Nothing of significance

 
 
 
 
 
 
International Union of Immunological SocietiesUniversity of South AfricaInstitute of Infectious Disease and Molecular MedicineElizabeth Glazer Pediatric Aids FoundationStellenbosch University